199 to present at the 10th ARDD Conference

We are excited to announce that 199 Biotechnologies will be participating in the 10th annual Aging Research and Drug Discovery (ARDD) conference from August 28-September ...
Read More →

$6.5M Seed Funding for Epigenetic Anti-Ageing Therapy

London-based startup 199 Biotechnologies announced today that it has secured $6.5M (£5.25M) in seed funding from a group of London-based private investors focused on Longevity ...
Read More →